(1->4)-beta-D-glucan multiple interactions ISO Prxl2a (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of PRXL2A mRNA CTD PMID:36331819 1,2-dichloroethane decreases expression ISO Prxl2a (Mus musculus) 6480464 ethylene dichloride results in decreased expression of PRXL2A mRNA CTD PMID:28189721 1,2-dimethylhydrazine multiple interactions ISO Prxl2a (Mus musculus) 6480464 [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of PRXL2A mRNA CTD PMID:22206623 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of PRXL2A mRNA CTD PMID:30723492 17beta-estradiol increases expression ISO Prxl2a (Mus musculus) 6480464 Estradiol results in increased expression of PRXL2A mRNA CTD PMID:30077407 17beta-estradiol multiple interactions ISO Prxl2a (Mus musculus) 6480464 [Polyphenols co-treated with Estradiol] results in increased expression of PRXL2A mRNA CTD PMID:30077407 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO Prxl2a (Mus musculus) 6480464 [NR1I2 protein affects the susceptibility to 2 more ... CTD PMID:32352317 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO PRXL2A (Homo sapiens) 6480464 Tetrachlorodibenzodioxin results in decreased expression of PRXL2A mRNA CTD PMID:17101203 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of PRXL2A mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO PRXL2A (Homo sapiens) 6480464 Tetrachlorodibenzodioxin results in increased expression of PRXL2A mRNA CTD PMID:20106945 and PMID:21632981 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of PRXL2A mRNA CTD PMID:22298810 2,3,7,8-Tetrachlorodibenzofuran increases expression EXP 6480464 2 more ... CTD PMID:32109520 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO PRXL2A (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of PRXL2A mRNA CTD PMID:28628672 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO Prxl2a (Mus musculus) 6480464 [1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] results in increased expression of PRXL2A mRNA CTD PMID:24848799 4,4'-sulfonyldiphenol increases expression ISO PRXL2A (Homo sapiens) 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of PRXL2A mRNA and bis(4-hydroxyphenyl)sulfone results in increased expression of PRXL2A protein CTD PMID:27685785 and PMID:34186270 4-hydroxyphenyl retinamide decreases expression ISO Prxl2a (Mus musculus) 6480464 Fenretinide results in decreased expression of PRXL2A mRNA CTD PMID:28973697 acetamide decreases expression EXP 6480464 acetamide results in decreased expression of PRXL2A mRNA CTD PMID:31881176 acrolein multiple interactions ISO PRXL2A (Homo sapiens) 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of PRXL2A mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of PRXL2A mRNA CTD PMID:32699268 aflatoxin B1 affects expression ISO PRXL2A (Homo sapiens) 6480464 Aflatoxin B1 affects the expression of PRXL2A protein CTD PMID:20106945 aflatoxin B1 decreases expression ISO PRXL2A (Homo sapiens) 6480464 Aflatoxin B1 results in decreased expression of PRXL2A mRNA CTD PMID:27153756 all-trans-retinoic acid increases expression ISO PRXL2A (Homo sapiens) 6480464 Tretinoin results in increased expression of PRXL2A mRNA CTD PMID:21934132 and PMID:23830798 all-trans-retinoic acid decreases expression EXP 6480464 Tretinoin results in decreased expression of PRXL2A mRNA CTD PMID:20488242 alpha-pinene multiple interactions ISO PRXL2A (Homo sapiens) 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of PRXL2A mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of PRXL2A mRNA CTD PMID:32699268 aristolochic acid A increases expression ISO PRXL2A (Homo sapiens) 6480464 aristolochic acid I results in increased expression of PRXL2A mRNA CTD PMID:33212167 arsane affects methylation ISO PRXL2A (Homo sapiens) 6480464 Arsenic affects the methylation of PRXL2A gene CTD PMID:25304211 arsane increases expression EXP 6480464 Arsenic results in increased expression of PRXL2A protein CTD PMID:34352348 arsenic atom affects methylation ISO PRXL2A (Homo sapiens) 6480464 Arsenic affects the methylation of PRXL2A gene CTD PMID:25304211 arsenic atom increases expression EXP 6480464 Arsenic results in increased expression of PRXL2A protein CTD PMID:34352348 benzo[a]pyrene affects methylation ISO PRXL2A (Homo sapiens) 6480464 Benzo(a)pyrene affects the methylation of PRXL2A 5' UTR CTD PMID:27901495 benzo[a]pyrene decreases expression ISO PRXL2A (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased expression of PRXL2A mRNA CTD PMID:32234424 benzo[a]pyrene decreases methylation ISO PRXL2A (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased methylation of PRXL2A promoter CTD PMID:27901495 bisphenol A increases expression ISO PRXL2A (Homo sapiens) 6480464 bisphenol A results in increased expression of PRXL2A mRNA and bisphenol A results in increased expression of PRXL2A protein CTD PMID:27685785 and PMID:34186270 bisphenol A increases expression ISO Prxl2a (Mus musculus) 6480464 bisphenol A results in increased expression of PRXL2A mRNA CTD PMID:34585602 bisphenol A decreases expression ISO Prxl2a (Mus musculus) 6480464 bisphenol A results in decreased expression of PRXL2A mRNA CTD PMID:30245210 and PMID:33221593 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of PRXL2A mRNA CTD PMID:30816183 more ... bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of PRXL2A gene CTD PMID:28505145 Bisphenol B increases expression ISO PRXL2A (Homo sapiens) 6480464 bisphenol B results in increased expression of PRXL2A protein CTD PMID:34186270 bisphenol F increases expression ISO PRXL2A (Homo sapiens) 6480464 bisphenol F results in increased expression of PRXL2A protein CTD PMID:34186270 Brodifacoum increases expression EXP 6480464 bromfenacoum results in increased expression of PRXL2A protein CTD PMID:28903499 cadmium atom multiple interactions ISO PRXL2A (Homo sapiens) 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PRXL2A mRNA CTD PMID:35301059 cadmium dichloride multiple interactions ISO PRXL2A (Homo sapiens) 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PRXL2A mRNA CTD PMID:35301059 carbon nanotube decreases expression ISO Prxl2a (Mus musculus) 6480464 Nanotubes more ... CTD PMID:25554681 and PMID:25620056 chloropicrin increases expression ISO PRXL2A (Homo sapiens) 6480464 chloropicrin results in increased expression of PRXL2A mRNA CTD PMID:26352163 chromium(6+) affects expression ISO Prxl2a (Mus musculus) 6480464 chromium hexavalent ion affects the expression of PRXL2A mRNA CTD PMID:28472532 cisplatin increases expression ISO PRXL2A (Homo sapiens) 6480464 Cisplatin results in increased expression of PRXL2A mRNA CTD PMID:27392435 cisplatin increases expression EXP 6480464 Cisplatin results in increased expression of PRXL2A protein CTD PMID:22023808 cisplatin multiple interactions ISO PRXL2A (Homo sapiens) 6480464 [Cisplatin co-treated with jinfukang] results in increased expression of PRXL2A mRNA CTD PMID:27392435 clofibric acid affects expression EXP 6480464 Clofibric Acid affects the expression of PRXL2A mRNA CTD PMID:17602206 copper(II) sulfate decreases expression ISO PRXL2A (Homo sapiens) 6480464 Copper Sulfate results in decreased expression of PRXL2A mRNA CTD PMID:19549813 crocidolite asbestos decreases expression ISO PRXL2A (Homo sapiens) 6480464 Asbestos and Crocidolite results in decreased expression of PRXL2A mRNA CTD PMID:29523930 Cuprizon multiple interactions ISO PRXL2A (Homo sapiens) 6480464 [Cuprizone co-treated with Haloperidol] results in increased expression of PRXL2A protein CTD PMID:34122009 cyclosporin A decreases expression ISO PRXL2A (Homo sapiens) 6480464 Cyclosporine results in decreased expression of PRXL2A mRNA CTD PMID:20106945 and PMID:25562108 cypermethrin decreases expression ISO Prxl2a (Mus musculus) 6480464 cypermethrin results in decreased expression of PRXL2A mRNA CTD PMID:29020013 dexamethasone increases expression ISO PRXL2A (Homo sapiens) 6480464 Dexamethasone results in increased expression of PRXL2A mRNA CTD PMID:25047013 dexamethasone multiple interactions ISO Prxl2a (Mus musculus) 6480464 [1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] results in increased expression of PRXL2A mRNA CTD PMID:24848799 dexamethasone multiple interactions ISO PRXL2A (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of PRXL2A mRNA CTD PMID:28628672 dicrotophos decreases expression ISO PRXL2A (Homo sapiens) 6480464 dicrotophos results in decreased expression of PRXL2A mRNA CTD PMID:28302478 dorsomorphin multiple interactions ISO PRXL2A (Homo sapiens) 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin increases expression ISO PRXL2A (Homo sapiens) 6480464 Doxorubicin results in increased expression of PRXL2A mRNA CTD PMID:29803840 epoxiconazole decreases expression ISO Prxl2a (Mus musculus) 6480464 epoxiconazole results in decreased expression of PRXL2A mRNA CTD PMID:35436446 ethanol increases expression ISO Prxl2a (Mus musculus) 6480464 Ethanol results in increased expression of PRXL2A mRNA CTD PMID:30319688 ethyl methanesulfonate increases expression ISO PRXL2A (Homo sapiens) 6480464 Ethyl Methanesulfonate results in increased expression of PRXL2A mRNA CTD PMID:23649840 folic acid multiple interactions ISO Prxl2a (Mus musculus) 6480464 [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of PRXL2A mRNA CTD PMID:22206623 formaldehyde increases expression ISO PRXL2A (Homo sapiens) 6480464 Formaldehyde results in increased expression of PRXL2A mRNA CTD PMID:23649840 furan increases methylation EXP 6480464 furan results in increased methylation of PRXL2A gene CTD PMID:22079235 genistein increases expression ISO Prxl2a (Mus musculus) 6480464 Genistein results in increased expression of PRXL2A mRNA CTD PMID:32186404 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of PRXL2A mRNA CTD PMID:33387578 haloperidol multiple interactions ISO PRXL2A (Homo sapiens) 6480464 [Cuprizone co-treated with Haloperidol] results in increased expression of PRXL2A protein CTD PMID:34122009 indometacin multiple interactions ISO PRXL2A (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of PRXL2A mRNA CTD PMID:28628672 inulin multiple interactions ISO Prxl2a (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of PRXL2A mRNA CTD PMID:36331819 ivermectin decreases expression ISO PRXL2A (Homo sapiens) 6480464 Ivermectin results in decreased expression of PRXL2A protein CTD PMID:32959892 lipopolysaccharide decreases expression ISO Prxl2a (Mus musculus) 6480464 Lipopolysaccharides results in decreased expression of PRXL2A mRNA CTD PMID:27339419 manganese(II) chloride increases methylation EXP 6480464 manganese chloride results in increased methylation of PRXL2A gene CTD PMID:28801915 manganese(II) chloride decreases expression EXP 6480464 manganese chloride results in decreased expression of PRXL2A mRNA CTD PMID:28801915 nickel atom decreases expression ISO PRXL2A (Homo sapiens) 6480464 Nickel results in decreased expression of PRXL2A mRNA CTD PMID:25583101 nitrofen increases expression EXP 6480464 nitrofen results in increased expression of PRXL2A mRNA CTD PMID:33484710 ozone multiple interactions ISO PRXL2A (Homo sapiens) 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of PRXL2A mRNA more ... CTD PMID:32699268 paracetamol decreases expression ISO PRXL2A (Homo sapiens) 6480464 Acetaminophen results in decreased expression of PRXL2A mRNA CTD PMID:29067470 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of PRXL2A mRNA CTD PMID:33387578 perfluorooctane-1-sulfonic acid multiple interactions ISO Prxl2a (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of PRXL2A mRNA more ... CTD PMID:36331819 phenobarbital affects expression ISO Prxl2a (Mus musculus) 6480464 Phenobarbital affects the expression of PRXL2A mRNA CTD PMID:23091169 potassium chromate increases expression ISO PRXL2A (Homo sapiens) 6480464 potassium chromate(VI) results in increased expression of PRXL2A mRNA CTD PMID:22714537 resveratrol multiple interactions ISO PRXL2A (Homo sapiens) 6480464 [Plant Extracts co-treated with Resveratrol] results in increased expression of PRXL2A mRNA CTD PMID:23557933 rotenone increases expression EXP 6480464 Rotenone results in increased expression of PRXL2A protein CTD PMID:35544339 SB 431542 multiple interactions ISO PRXL2A (Homo sapiens) 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 sodium arsenate decreases expression ISO Prxl2a (Mus musculus) 6480464 sodium arsenate results in decreased expression of PRXL2A mRNA CTD PMID:30953684 sodium fluoride increases expression ISO Prxl2a (Mus musculus) 6480464 Sodium Fluoride results in increased expression of PRXL2A protein CTD PMID:28918527 sunitinib increases expression ISO PRXL2A (Homo sapiens) 6480464 Sunitinib results in increased expression of PRXL2A mRNA CTD PMID:31533062 temozolomide decreases expression ISO PRXL2A (Homo sapiens) 6480464 Temozolomide results in decreased expression of PRXL2A mRNA CTD PMID:31758290 tetrachloromethane decreases expression ISO Prxl2a (Mus musculus) 6480464 Carbon Tetrachloride results in decreased expression of PRXL2A mRNA CTD PMID:27339419 and PMID:31919559 thalidomide decreases expression ISO Prxl2a (Mus musculus) 6480464 Thalidomide results in decreased expression of PRXL2A mRNA CTD PMID:26217789 thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of PRXL2A mRNA CTD PMID:34492290 titanium dioxide decreases expression ISO Prxl2a (Mus musculus) 6480464 titanium dioxide results in decreased expression of PRXL2A mRNA CTD PMID:23557971 tolcapone affects binding EXP 6480464 tolcapone binds to PRXL2A protein CTD PMID:19783845 tributylstannane increases expression ISO Prxl2a (Mus musculus) 6480464 tributyltin results in increased expression of PRXL2A mRNA CTD PMID:24848799 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of PRXL2A mRNA CTD PMID:33387578 trichostatin A decreases expression ISO PRXL2A (Homo sapiens) 6480464 trichostatin A results in decreased expression of PRXL2A mRNA CTD PMID:24935251 and PMID:26272509 trichostatin A multiple interactions ISO PRXL2A (Homo sapiens) 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PRXL2A mRNA CTD PMID:27188386 tungsten decreases expression ISO Prxl2a (Mus musculus) 6480464 Tungsten results in decreased expression of PRXL2A mRNA CTD PMID:30912803 valproic acid increases expression ISO PRXL2A (Homo sapiens) 6480464 Valproic Acid results in increased expression of PRXL2A mRNA CTD PMID:19101580 and PMID:23179753 valproic acid decreases expression ISO PRXL2A (Homo sapiens) 6480464 Valproic Acid results in decreased expression of PRXL2A mRNA CTD PMID:23179753 and PMID:26272509 valproic acid multiple interactions ISO PRXL2A (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PRXL2A mRNA CTD PMID:27188386